Amphetamine sensitization impairs cognition and reduces dopamine turnover in primate prefrontal cortex

Amphetamine (AMPH) sensitization in monkeys produces long-lasting behavioral changes that model positive (hallucinatory-like behaviors) and negative (psychomotor depression) symptoms of schizophrenia. The extent to which this model produces the core deficit in schizophrenia—working memory impairment...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Biological psychiatry (1969) 2005-04, Vol.57 (7), p.743-751
Hauptverfasser: Castner, Stacy A., Vosler, Peter S., Goldman-Rakic, Patricia S.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 751
container_issue 7
container_start_page 743
container_title Biological psychiatry (1969)
container_volume 57
creator Castner, Stacy A.
Vosler, Peter S.
Goldman-Rakic, Patricia S.
description Amphetamine (AMPH) sensitization in monkeys produces long-lasting behavioral changes that model positive (hallucinatory-like behaviors) and negative (psychomotor depression) symptoms of schizophrenia. The extent to which this model produces the core deficit in schizophrenia—working memory impairment—is unknown. Two groups of rhesus monkeys were sensitized to AMPH over 6 weeks. In one group, acquisition of cognitive tasks (delayed response, visual discrimination, delayed nonmatch-to-sample) was examined beginning 6+ months postsensitization. The second group was pretrained to stability on delayed response before sensitization. Regional postmortem concentrations of dopamine and its metabolites were examined in tissue from age-matched AMPH-naïve and AMPH-sensitized monkeys using high-performance liquid chromatography with electrochemical detection (HPLC-ECD). The AMPH-sensitized monkeys were profoundly impaired in their ability to acquire cognitive tasks compared with AMPH-naïve monkeys. Pretrained monkeys showed impaired delayed response performance for several months following sensitization. Analysis by HPLC revealed that AMPH sensitization significantly reduced dopamine turnover in prefrontal cortex and striatum. Impairments in the acquisition and performance of spatial delayed response in association with reduced dopamine turnover in prefrontal cortex following AMPH sensitization provide further support for the relevance of this model to both the etiology and the treatment of cognitive dysfunction in schizophrenia.
doi_str_mv 10.1016/j.biopsych.2004.12.019
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_17323985</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S000632230401323X</els_id><sourcerecordid>17323985</sourcerecordid><originalsourceid>FETCH-LOGICAL-c427t-557476ae3464f5f53603e74e87be2a1e56f2fbb18c0d90c8589ddb1f6ab859273</originalsourceid><addsrcrecordid>eNqFkMtu1TAURS0EorePX6gygVmCH7GdzKgqoEiVOiljy7GPqa8SO9hORfl63N6LOmR0dKy1j7cWQpcEdwQT8WnfTT6u-ck8dBTjviO0w2R8g3ZkkKylPaZv0Q5jLFpGKTtBpznv6yopJe_RCeEDxZSRHXJXy_oARS8-QJMhZF_8H118DI1fVu1Tbkz8GfzLiw62SWA3A7mxcT2EypZCfITU-NCsyS-6QJ3gUgxFzzWdCvw-R--cnjNcHOcZ-vH1y_31TXt79-379dVta3oqS8u57KXQwHrRO-44E5iB7GGQE1BNgAtH3TSRwWA7YjPwYbR2Ik7oaeAjlewMfTzcXVP8tUEuavHZwDzrAHHLikhG2TjwCooDaFLMudZVL93TkyJYPRtWe_XPsHo2rAhV1XANXh5_2KYF7GvsqLQCH46AzkbPLulgfH7lhGSMkr5ynw8cVB-PHpLKxkMwYH0CU5SN_n9d_gLTiZ-j</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17323985</pqid></control><display><type>article</type><title>Amphetamine sensitization impairs cognition and reduces dopamine turnover in primate prefrontal cortex</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Castner, Stacy A. ; Vosler, Peter S. ; Goldman-Rakic, Patricia S.</creator><creatorcontrib>Castner, Stacy A. ; Vosler, Peter S. ; Goldman-Rakic, Patricia S.</creatorcontrib><description>Amphetamine (AMPH) sensitization in monkeys produces long-lasting behavioral changes that model positive (hallucinatory-like behaviors) and negative (psychomotor depression) symptoms of schizophrenia. The extent to which this model produces the core deficit in schizophrenia—working memory impairment—is unknown. Two groups of rhesus monkeys were sensitized to AMPH over 6 weeks. In one group, acquisition of cognitive tasks (delayed response, visual discrimination, delayed nonmatch-to-sample) was examined beginning 6+ months postsensitization. The second group was pretrained to stability on delayed response before sensitization. Regional postmortem concentrations of dopamine and its metabolites were examined in tissue from age-matched AMPH-naïve and AMPH-sensitized monkeys using high-performance liquid chromatography with electrochemical detection (HPLC-ECD). The AMPH-sensitized monkeys were profoundly impaired in their ability to acquire cognitive tasks compared with AMPH-naïve monkeys. Pretrained monkeys showed impaired delayed response performance for several months following sensitization. Analysis by HPLC revealed that AMPH sensitization significantly reduced dopamine turnover in prefrontal cortex and striatum. Impairments in the acquisition and performance of spatial delayed response in association with reduced dopamine turnover in prefrontal cortex following AMPH sensitization provide further support for the relevance of this model to both the etiology and the treatment of cognitive dysfunction in schizophrenia.</description><identifier>ISSN: 0006-3223</identifier><identifier>EISSN: 1873-2402</identifier><identifier>DOI: 10.1016/j.biopsych.2004.12.019</identifier><identifier>PMID: 15820231</identifier><identifier>CODEN: BIPCBF</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>3,4-Dihydroxyphenylacetic Acid - metabolism ; Adult and adolescent clinical studies ; Amphetamine - adverse effects ; Amphetamine - pharmacology ; Analysis of Variance ; Animals ; Behavior, Animal - drug effects ; Behavioral psychophysiology ; Behavioral sensitization ; Biological and medical sciences ; Central Nervous System Stimulants - adverse effects ; Central Nervous System Stimulants - pharmacology ; Chromatography, High Pressure Liquid - methods ; Cognition Disorders - chemically induced ; Cognition Disorders - physiopathology ; Corpus Striatum - metabolism ; Discrimination Learning - drug effects ; Dopamine - metabolism ; dopamine transmission ; dorsolateral prefrontal cortex ; Electrochemistry - methods ; Female ; Fundamental and applied biological sciences. Psychology ; Homovanillic Acid - metabolism ; Macaca mulatta ; Male ; Medical sciences ; Neuropsychological Tests - statistics &amp; numerical data ; Neurotransmission and behavior ; nonhuman primate ; Prefrontal Cortex - drug effects ; Prefrontal Cortex - metabolism ; Prefrontal Cortex - physiopathology ; Psychology. Psychoanalysis. Psychiatry ; Psychology. Psychophysiology ; Psychopathology. Psychiatry ; Psychoses ; Reaction Time - drug effects ; Reward ; Schizophrenia ; spatial working memory ; Time Factors ; Visual Perception - drug effects</subject><ispartof>Biological psychiatry (1969), 2005-04, Vol.57 (7), p.743-751</ispartof><rights>2005 Society of Biological Psychiatry</rights><rights>2005 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c427t-557476ae3464f5f53603e74e87be2a1e56f2fbb18c0d90c8589ddb1f6ab859273</citedby><cites>FETCH-LOGICAL-c427t-557476ae3464f5f53603e74e87be2a1e56f2fbb18c0d90c8589ddb1f6ab859273</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.biopsych.2004.12.019$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3548,27922,27923,45993</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=16733214$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15820231$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Castner, Stacy A.</creatorcontrib><creatorcontrib>Vosler, Peter S.</creatorcontrib><creatorcontrib>Goldman-Rakic, Patricia S.</creatorcontrib><title>Amphetamine sensitization impairs cognition and reduces dopamine turnover in primate prefrontal cortex</title><title>Biological psychiatry (1969)</title><addtitle>Biol Psychiatry</addtitle><description>Amphetamine (AMPH) sensitization in monkeys produces long-lasting behavioral changes that model positive (hallucinatory-like behaviors) and negative (psychomotor depression) symptoms of schizophrenia. The extent to which this model produces the core deficit in schizophrenia—working memory impairment—is unknown. Two groups of rhesus monkeys were sensitized to AMPH over 6 weeks. In one group, acquisition of cognitive tasks (delayed response, visual discrimination, delayed nonmatch-to-sample) was examined beginning 6+ months postsensitization. The second group was pretrained to stability on delayed response before sensitization. Regional postmortem concentrations of dopamine and its metabolites were examined in tissue from age-matched AMPH-naïve and AMPH-sensitized monkeys using high-performance liquid chromatography with electrochemical detection (HPLC-ECD). The AMPH-sensitized monkeys were profoundly impaired in their ability to acquire cognitive tasks compared with AMPH-naïve monkeys. Pretrained monkeys showed impaired delayed response performance for several months following sensitization. Analysis by HPLC revealed that AMPH sensitization significantly reduced dopamine turnover in prefrontal cortex and striatum. Impairments in the acquisition and performance of spatial delayed response in association with reduced dopamine turnover in prefrontal cortex following AMPH sensitization provide further support for the relevance of this model to both the etiology and the treatment of cognitive dysfunction in schizophrenia.</description><subject>3,4-Dihydroxyphenylacetic Acid - metabolism</subject><subject>Adult and adolescent clinical studies</subject><subject>Amphetamine - adverse effects</subject><subject>Amphetamine - pharmacology</subject><subject>Analysis of Variance</subject><subject>Animals</subject><subject>Behavior, Animal - drug effects</subject><subject>Behavioral psychophysiology</subject><subject>Behavioral sensitization</subject><subject>Biological and medical sciences</subject><subject>Central Nervous System Stimulants - adverse effects</subject><subject>Central Nervous System Stimulants - pharmacology</subject><subject>Chromatography, High Pressure Liquid - methods</subject><subject>Cognition Disorders - chemically induced</subject><subject>Cognition Disorders - physiopathology</subject><subject>Corpus Striatum - metabolism</subject><subject>Discrimination Learning - drug effects</subject><subject>Dopamine - metabolism</subject><subject>dopamine transmission</subject><subject>dorsolateral prefrontal cortex</subject><subject>Electrochemistry - methods</subject><subject>Female</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Homovanillic Acid - metabolism</subject><subject>Macaca mulatta</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Neuropsychological Tests - statistics &amp; numerical data</subject><subject>Neurotransmission and behavior</subject><subject>nonhuman primate</subject><subject>Prefrontal Cortex - drug effects</subject><subject>Prefrontal Cortex - metabolism</subject><subject>Prefrontal Cortex - physiopathology</subject><subject>Psychology. Psychoanalysis. Psychiatry</subject><subject>Psychology. Psychophysiology</subject><subject>Psychopathology. Psychiatry</subject><subject>Psychoses</subject><subject>Reaction Time - drug effects</subject><subject>Reward</subject><subject>Schizophrenia</subject><subject>spatial working memory</subject><subject>Time Factors</subject><subject>Visual Perception - drug effects</subject><issn>0006-3223</issn><issn>1873-2402</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkMtu1TAURS0EorePX6gygVmCH7GdzKgqoEiVOiljy7GPqa8SO9hORfl63N6LOmR0dKy1j7cWQpcEdwQT8WnfTT6u-ck8dBTjviO0w2R8g3ZkkKylPaZv0Q5jLFpGKTtBpznv6yopJe_RCeEDxZSRHXJXy_oARS8-QJMhZF_8H118DI1fVu1Tbkz8GfzLiw62SWA3A7mxcT2EypZCfITU-NCsyS-6QJ3gUgxFzzWdCvw-R--cnjNcHOcZ-vH1y_31TXt79-379dVta3oqS8u57KXQwHrRO-44E5iB7GGQE1BNgAtH3TSRwWA7YjPwYbR2Ik7oaeAjlewMfTzcXVP8tUEuavHZwDzrAHHLikhG2TjwCooDaFLMudZVL93TkyJYPRtWe_XPsHo2rAhV1XANXh5_2KYF7GvsqLQCH46AzkbPLulgfH7lhGSMkr5ynw8cVB-PHpLKxkMwYH0CU5SN_n9d_gLTiZ-j</recordid><startdate>20050401</startdate><enddate>20050401</enddate><creator>Castner, Stacy A.</creator><creator>Vosler, Peter S.</creator><creator>Goldman-Rakic, Patricia S.</creator><general>Elsevier Inc</general><general>Elsevier Science</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope></search><sort><creationdate>20050401</creationdate><title>Amphetamine sensitization impairs cognition and reduces dopamine turnover in primate prefrontal cortex</title><author>Castner, Stacy A. ; Vosler, Peter S. ; Goldman-Rakic, Patricia S.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c427t-557476ae3464f5f53603e74e87be2a1e56f2fbb18c0d90c8589ddb1f6ab859273</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>3,4-Dihydroxyphenylacetic Acid - metabolism</topic><topic>Adult and adolescent clinical studies</topic><topic>Amphetamine - adverse effects</topic><topic>Amphetamine - pharmacology</topic><topic>Analysis of Variance</topic><topic>Animals</topic><topic>Behavior, Animal - drug effects</topic><topic>Behavioral psychophysiology</topic><topic>Behavioral sensitization</topic><topic>Biological and medical sciences</topic><topic>Central Nervous System Stimulants - adverse effects</topic><topic>Central Nervous System Stimulants - pharmacology</topic><topic>Chromatography, High Pressure Liquid - methods</topic><topic>Cognition Disorders - chemically induced</topic><topic>Cognition Disorders - physiopathology</topic><topic>Corpus Striatum - metabolism</topic><topic>Discrimination Learning - drug effects</topic><topic>Dopamine - metabolism</topic><topic>dopamine transmission</topic><topic>dorsolateral prefrontal cortex</topic><topic>Electrochemistry - methods</topic><topic>Female</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Homovanillic Acid - metabolism</topic><topic>Macaca mulatta</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Neuropsychological Tests - statistics &amp; numerical data</topic><topic>Neurotransmission and behavior</topic><topic>nonhuman primate</topic><topic>Prefrontal Cortex - drug effects</topic><topic>Prefrontal Cortex - metabolism</topic><topic>Prefrontal Cortex - physiopathology</topic><topic>Psychology. Psychoanalysis. Psychiatry</topic><topic>Psychology. Psychophysiology</topic><topic>Psychopathology. Psychiatry</topic><topic>Psychoses</topic><topic>Reaction Time - drug effects</topic><topic>Reward</topic><topic>Schizophrenia</topic><topic>spatial working memory</topic><topic>Time Factors</topic><topic>Visual Perception - drug effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Castner, Stacy A.</creatorcontrib><creatorcontrib>Vosler, Peter S.</creatorcontrib><creatorcontrib>Goldman-Rakic, Patricia S.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><jtitle>Biological psychiatry (1969)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Castner, Stacy A.</au><au>Vosler, Peter S.</au><au>Goldman-Rakic, Patricia S.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Amphetamine sensitization impairs cognition and reduces dopamine turnover in primate prefrontal cortex</atitle><jtitle>Biological psychiatry (1969)</jtitle><addtitle>Biol Psychiatry</addtitle><date>2005-04-01</date><risdate>2005</risdate><volume>57</volume><issue>7</issue><spage>743</spage><epage>751</epage><pages>743-751</pages><issn>0006-3223</issn><eissn>1873-2402</eissn><coden>BIPCBF</coden><abstract>Amphetamine (AMPH) sensitization in monkeys produces long-lasting behavioral changes that model positive (hallucinatory-like behaviors) and negative (psychomotor depression) symptoms of schizophrenia. The extent to which this model produces the core deficit in schizophrenia—working memory impairment—is unknown. Two groups of rhesus monkeys were sensitized to AMPH over 6 weeks. In one group, acquisition of cognitive tasks (delayed response, visual discrimination, delayed nonmatch-to-sample) was examined beginning 6+ months postsensitization. The second group was pretrained to stability on delayed response before sensitization. Regional postmortem concentrations of dopamine and its metabolites were examined in tissue from age-matched AMPH-naïve and AMPH-sensitized monkeys using high-performance liquid chromatography with electrochemical detection (HPLC-ECD). The AMPH-sensitized monkeys were profoundly impaired in their ability to acquire cognitive tasks compared with AMPH-naïve monkeys. Pretrained monkeys showed impaired delayed response performance for several months following sensitization. Analysis by HPLC revealed that AMPH sensitization significantly reduced dopamine turnover in prefrontal cortex and striatum. Impairments in the acquisition and performance of spatial delayed response in association with reduced dopamine turnover in prefrontal cortex following AMPH sensitization provide further support for the relevance of this model to both the etiology and the treatment of cognitive dysfunction in schizophrenia.</abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>15820231</pmid><doi>10.1016/j.biopsych.2004.12.019</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0006-3223
ispartof Biological psychiatry (1969), 2005-04, Vol.57 (7), p.743-751
issn 0006-3223
1873-2402
language eng
recordid cdi_proquest_miscellaneous_17323985
source MEDLINE; Elsevier ScienceDirect Journals Complete
subjects 3,4-Dihydroxyphenylacetic Acid - metabolism
Adult and adolescent clinical studies
Amphetamine - adverse effects
Amphetamine - pharmacology
Analysis of Variance
Animals
Behavior, Animal - drug effects
Behavioral psychophysiology
Behavioral sensitization
Biological and medical sciences
Central Nervous System Stimulants - adverse effects
Central Nervous System Stimulants - pharmacology
Chromatography, High Pressure Liquid - methods
Cognition Disorders - chemically induced
Cognition Disorders - physiopathology
Corpus Striatum - metabolism
Discrimination Learning - drug effects
Dopamine - metabolism
dopamine transmission
dorsolateral prefrontal cortex
Electrochemistry - methods
Female
Fundamental and applied biological sciences. Psychology
Homovanillic Acid - metabolism
Macaca mulatta
Male
Medical sciences
Neuropsychological Tests - statistics & numerical data
Neurotransmission and behavior
nonhuman primate
Prefrontal Cortex - drug effects
Prefrontal Cortex - metabolism
Prefrontal Cortex - physiopathology
Psychology. Psychoanalysis. Psychiatry
Psychology. Psychophysiology
Psychopathology. Psychiatry
Psychoses
Reaction Time - drug effects
Reward
Schizophrenia
spatial working memory
Time Factors
Visual Perception - drug effects
title Amphetamine sensitization impairs cognition and reduces dopamine turnover in primate prefrontal cortex
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-10T06%3A07%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Amphetamine%20sensitization%20impairs%20cognition%20and%20reduces%20dopamine%20turnover%20in%20primate%20prefrontal%20cortex&rft.jtitle=Biological%20psychiatry%20(1969)&rft.au=Castner,%20Stacy%20A.&rft.date=2005-04-01&rft.volume=57&rft.issue=7&rft.spage=743&rft.epage=751&rft.pages=743-751&rft.issn=0006-3223&rft.eissn=1873-2402&rft.coden=BIPCBF&rft_id=info:doi/10.1016/j.biopsych.2004.12.019&rft_dat=%3Cproquest_cross%3E17323985%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=17323985&rft_id=info:pmid/15820231&rft_els_id=S000632230401323X&rfr_iscdi=true